Skip to main content
Molina Healthcare Inc (MOH)
Health Services Health Care
Stock AI

Molina Healthcare Inc. Reports Strong Q1 2024 Financial Results Amid Regulatory Changes

Last updated: April 25, 2024
Taurigo

Molina Healthcare Inc. has released its first quarter financial results for 2024, showcasing robust growth in revenue and membership amidst a dynamic regulatory environment. The company’s performance highlights its strategic initiatives in expanding its Medicaid and Medicare segments while navigating the complexities post the Public Health Emergency (PHE).

1. Key Financial Highlights

For the first quarter of 2024, Molina Healthcare reported:

  • Net Income: $301 million, translating to $5.17 per diluted share.
  • Operating Income: $426 million.
  • Premium Revenue: $9.5 billion, representing a 21% increase from the same period in 2023.
  • Medical Care Ratio (MCR): 88.5%, slightly up from 87.1% year-over-year.
  • General and Administrative (G&A) Ratio: 7.2%, consistent with Q1 2023.

Income Statement Overview

The following table outlines the income statement for Q1 2023 and Q1 2024:

Income Statement of Molina Healthcare Inc
Apr 2023 Apr 2024
Net Income
855M1.07B
Profit
855M1.07B
Net Income Continuing
855M1.07B
Income Tax Expense
291M365M
Pretax Income
1.14B1.43B
Non-operating Income
-110M-108M
Operating Income
1.25B1.54B
Revenue
32.35B35.85B
Costs and Expenses
31.09B34.31B
Cost of Revenue
27.48B30.21B
Operating Expenses
3.61B4.09B
Depreciation, Depletion & Amortization
180M172M
Impairment Expense
208M0
Selling, General & Administrative
2.33B2.58B
Other Operating Expenses
895M1.34B

2. Membership Growth and Market Expansion

Molina Healthcare's total membership reached 5.7 million as of March 31, 2024, marking a 9% increase year-over-year. This growth is attributed primarily to:

  • The commencement of new Medicaid contracts in Iowa and Nebraska.
  • The acquisition of Bright Health Medicare.
  • Expansion efforts in California, particularly in Los Angeles County.

The company estimates that it has added approximately one million new Medicaid members since the onset of the pandemic, with a retention expectation of around 40% of this new membership.

3. Segment Financial Performance

Medicaid Segment

  • Membership: 4,441,000
  • Premium Revenue: $4.4 billion
  • Medical Margin: $243 million
  • MCR: 89.7%

The Medicaid segment experienced a 6% increase in medical margin compared to Q1 2023, driven by higher premium revenues. However, MCR increased due to initial costs associated with new contracts.

Medicare Segment

  • Membership: 1,441,000
  • Premium Revenue: $1.4 billion (up 38% year-over-year)
  • Medical Margin: $137 million
  • MCR: 88.7%

The Medicare segment saw significant growth, particularly from the Bright Health acquisition, contributing to a substantial rise in premium revenue and membership.

Marketplace Segment

  • Membership: 825,000
  • Premium Revenue: $1.1 billion
  • Medical Margin: $63 million
  • MCR: 85.5%

Despite an increase in premium revenue, the Marketplace segment's medical margin slightly decreased, reflecting changes in member mix and MCR adjustments.

Other Segment

  • Membership: 50,000
  • Premium Revenue: $22 million
  • Medical Margin: $5 million
  • MCR: 80.0%

4. Liquidity and Capital Resources

As of March 31, 2024, Molina Healthcare reported total cash, cash equivalents, and investments of $9.2 billion, down from $9.4 billion at the end of 2023. The company maintains a solid financial position, with available borrowing capacity under its credit agreement of $1 billion, sufficient to support ongoing operations and strategic initiatives.

Cash Flow Overview

The following table summarizes the cash flow statement for Q1 2023 and Q1 2024:

Cash Flow Statement of Molina Healthcare Inc
Apr 2023 Apr 2024
Net Change in Cash
-269M-25M
Net Cash from Operating Activities
1.32B960M
Operating Profit
855M1.07B
Adjustment to Operating Profit
471M-111M
Net Cash from Investing Activities
-1.16B-930M
Business & Interest in Affiliates
134M298M
Investments
900M555M
Productive Assets
100M79M
Other Investing Activities
-32M2M
Net Cash from Financing Activities
-429M-55M
Equity Issuance/Repurchase
-340M58M
Other Financing Activities
-89M-113M

5. Future Outlook

Molina Healthcare is positioned for continued growth as it navigates a changing regulatory landscape. The expected end of the Public Health Emergency could impact certain healthcare programs, but the company remains optimistic about its ability to retain a significant portion of its expanded Medicaid membership.

Molina's management indicated ongoing commitment to enhancing healthcare access for low-income populations while strategically expanding its market presence through acquisitions and contract wins in various states.

Balance Sheet Summary

The balance sheet data highlights the company's strong asset base and manageable liabilities:

Balance Sheet of Molina Healthcare Inc
Apr 2023 Apr 2024
Total Assets
13.37B15.51B
Total Current Assets
11.15B12.66B
Cash and Equivalents
4.55B4.51B
Short-term Investments
3.81B4.42B
Prepaid Expenses
259M381M
Total Non-current Assets
2.21B2.84B
Intangible Assets
1.36B1.92B
Non-current Deferred Tax Assets
208M228M
Net PP&E
274M295M
Other Non-current Assets
361M395M
Total Liabilities and Equity
13.37B15.51B
Total Liabilities
10.08B11.02B
Total Current Liabilities
7.61B8.51B
Accounts Payable and Accrued Liabilities
787M1.11B
Current Deferred Revenue
654M328M
Other Current Liabilities
6.17B7.07B
Total Non-current Liabilities
2.46B2.50B
Long-term Debt
2.38B2.38B
Other Non-current Liabilities
88M124M
Total Equity and Non-controlling Interests
3.28B4.49B
Total Equity
3.28B4.49B

6. Conclusion

Molina Healthcare Inc.'s Q1 2024 results reflect a solid financial performance characterized by substantial revenue growth, strategic membership expansion, and a strong market position. As the company continues to adapt to regulatory changes and pursue growth opportunities, it remains focused on delivering quality healthcare services to its members across the United States.

You may also be interested in:
Copyright ©2026 Taurigo GmbH. All rights reserved.Taurigo GmbH provides no investment advice. Any analyses, research, ideas, prices, or other information contained on this website are provided as general market information for educational and entertainment purposes only, and do not constitute investment advice. We assume no responsibility for the accuracy, completeness or timeliness of any financial information contained on this site. In particular, we do not constitute an invitation to buy, sell or hold securities or other financial products. We shall not be liable for any loss or damage, including without limitation loss of profits, arising directly or indirectly from use of or reliance on the provided information. Before making any investment decision, you should consider whether it is suitable for your situation and obtain appropriate financial, tax and legal advice.